Phase II Study of Pembrolizumab Finds Activity in Brain Metastases from NSCLC

The study found that pembrolizumab has activity in brain metastases from non-small cell lung cancer that is similar to its systemic activity and can result in prolonged survival in a subset of patients.

Source: CancerNetwork - April 26, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news